EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intravasation‐On‐µDevice (INVADE): Engineering Dynamic Vascular Interfaces to Study Cancer Cell Intravasation

Fengtao Jiang, Yingqi Zhang, Guocheng Fang, Yao Wang, Alexander Dupuy, Jasmine Jin, Yi Shen, Khoon S Lim, Yinyan Wang, Yu Shrike Zhang iD, Ann-Na Cho, Hongxu Lu und 1 weitere

Advanced Materials · 2025

DOI: 10.1002/adma.202501466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Fengtao Jiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Faculty of Engineering, The University of Sydney, Darlington, NSW, 2008, Australia. Hauptthemen laut MEDLINE: Cell Line, Tumor, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSW Cardiovascular Capacity Building Program, Australian Research Council, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer metastasis begins with intravasation, where cancer cells enter blood vessels through complex interactions with the endothelial barrier. Understanding this process remains challenging due to the lack of physiologically relevant models. Here, INVADE (Intravasation‐on‐µDevice), a biomimetic microfluidic platform, is presented, enabling high‐throughput analysis of cancer cell intravasation under controlled conditions. This engineered platform integrates 23 parallel niche chambers with an endothelialized channel, providing both precise microenvironmental control and optical accessibility for real‐time visualization. Using this platform, distinct intravasation mechanisms are uncovered: MCF‐7 cells exhibit collective invasion, while MDA‐MB‐231 cells demonstrate an interactive mode with three functionally distinct subpopulations. A previously unknown epithelial‐mesenchymal transition (EMT) and mesenchymal‐epithelial transition (MET) switch is We discovered during intravasation, where MDA‐MB‐231 cells initially increase Vimentin expression before undergoing a 2.3 fold decrease over 96 h alongside a 1.5 fold increase in epithelial cell adhesion molecule (EpCAM). Remarkably, endothelial cells directly suppress cancer cell mesenchymal properties, as evidenced by a 4.6 fold reduction in Vimentin expression compared to mono‐cultures. Additionally, bilateral cancer‐endothelial interactions are revealed, aggressive cancer cells induce significant intercellular adhesion molecule‐1 (ICAM‐1) upregulation in endothelium. The INVADE platform represents an engineering advancement for studying complex cell–cell interactions with implications for understanding metastatic mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Line, TumorEpithelial-Mesenchymal TransitionHumansEpithelial Cell Adhesion MoleculeMCF-7 CellsNeoplasm InvasivenessVimentinMDA-MB-231 Cells

Stichwörter der Autor:innen

cancer metastasisendotheliumepithelial‐mesenchymal transitionintravasation, microfluidicsvimentin

Substanzen

Epithelial Cell Adhesion MoleculeVimentin

Autor:innen und Institutionen

  • School of Biomedical Engineering, Faculty of Engineering, The University of Sydney, Darlington, NSW, 2008, Australia.
  • School of Electrical & Electronic Engineering Nanyang Technological University, 50 Nanyang Avenue, Singapore, 639798, Singapore.
  • Charles Perkins Centre, The University of Sydney, Camperdown, NSW, 2006, Australia.
  • The University of Sydney Nano Institute (Sydney Nano), The University of Sydney, Camperdown, NS, 2006, Australia.
  • School of Chemical and Biomolecular Engineering, Faculty of Engineering, The University of Sydney, Darlington, NSW, 2008, Australia.
  • School of Medical Sciences, The University of Sydney, Darlington, NSW, 2008, Australia.

ORCID-Profile: Yu Shrike Zhang, Lining Arnold Ju

Förderung

  • NSW Cardiovascular Capacity Building Program
  • Australian Research Council
  • Wellcome Trust
  • MRFF Cardiovascular Health Mission Grants
  • Tour de Cure Pioneering Research
  • National Heart Foundation Vanguard
  • Snow Medical Research Foundation
  • the International Partnership Program of Chinese Academy of Sciences

Zitieren

APA

Jiang, F., Zhang, Y., Fang, G., Wang, Y., Dupuy, A., Jin, J., Shen, Y., Lim, K. S., Wang, Y., Zhang, Y. S., Cho, A. N., Lu, H., & Ju, L. A. (2025). Intravasation‐On‐µDevice (INVADE): Engineering Dynamic Vascular Interfaces to Study Cancer Cell Intravasation. Advanced Materials. https://doi.org/10.1002/adma.202501466

Vancouver

Jiang F, Zhang Y, Fang G, Wang Y, Dupuy A, Jin J, et al. Intravasation‐On‐µDevice (INVADE): Engineering Dynamic Vascular Interfaces to Study Cancer Cell Intravasation. Advanced Materials. 2025. doi:10.1002/adma.202501466

BibTeX
@article{Jiang2025,
  author = {Jiang, Fengtao and Zhang, Yingqi and Fang, Guocheng and Wang, Yao and Dupuy, Alexander and Jin, Jasmine and Shen, Yi and Lim, Khoon S and Wang, Yinyan and Zhang, Yu Shrike and Cho, Ann-Na and Lu, Hongxu and Ju, Lining Arnold},
  title = {Intravasation‐On‐µDevice (INVADE): Engineering Dynamic Vascular Interfaces to Study Cancer Cell Intravasation},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202501466}
}
Kostenlos starten →